Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations

BMC Biotechnology

Volumn 15, Issue 1, 2015, Pages

  Hassani Mehraban, Afshin ^a   Creutzburg, Sjoerd ^a   Heereveld, Luc ^a   Kormelink, Richard ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

CCMV; Foot and mouth disease virus; Influenza A virus; prokaryote expression system; Schmallenberg virus; viral nanoparticles; virus like particles; VLP

Indexed keywords

AMINO ACIDS; BIOSYNTHESIS; EPITOPES; ESCHERICHIA COLI; GENE EXPRESSION; PROTEINS; VACCINES; VIRUSES;

CCMV; EXPRESSION SYSTEM; FOOT-AND-MOUTH DISEASE VIRUS; INFLUENZA A VIRUS; VIRAL NANOPARTICLES; VIRUS-LIKE PARTICLES; VLP;

SCAFFOLDS (BIOLOGY);

2C PROTEIN; COAT PROTEIN; ECTODOMAIN MEMBRANE PROTEIN M2; EPITOPE; GC GLYCOPROTEIN; GN GLYCOPROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; MESSENGER RNA; PROTEIN VP1; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS PROTEIN; CAPSID PROTEIN; VIRUS LIKE PARTICLE VACCINE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; COWPEA CHLOROTIC MOTTLE VIRUS; ENCAPSULATION; ESCHERICHIA COLI; FOOT AND MOUTH DISEASE VIRUS; INFLUENZA A VIRUS; NONHUMAN; PROTEIN EXPRESSION; SCHMALLENBERG VIRUS; VIRUS LIKE AGENT; ANTIGEN PRESENTATION; BROMOVIRUS; CHEMISTRY; ELECTRON MICROSCOPY; EVALUATION STUDY; GENETIC ENGINEERING; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR MODEL; PLANT; PROCEDURES; VIROLOGY;

COWPEA CHLOROTIC MOTTLE VIRUS; FOOT-AND-MOUTH DISEASE VIRUS; INFLUENZA A VIRUS; ORTHOBUNYAVIRUS; PROKARYOTA;

ANTIGEN PRESENTATION; BROMOVIRUS; CAPSID PROTEINS; EPITOPES; ESCHERICHIA COLI; GENETIC ENGINEERING; MICROSCOPY, ELECTRON; MODELS, MOLECULAR; PLANTS; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84940200135     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/s12896-015-0180-6     Document Type: Article

References (60)

1. Lomonossoff GP, Evans DJ. Applications of plant viruses in bionantotechnology. Curr Top Microbiol Immunol. 2014;375:61-87.
2. Chen Q, Lai H. Plant-derived virus-like particles as vaccines. Hum Vaccin Immunother. 2013;9(1):26-49.
3. Hansson M, Nygren PA, Ståhl S. Design and production of recombinant subunit vaccines. Biotechnol Appl Biochem. 2000;32(Pt 2):95-107.
4. Noad R, Roy P. Virus-like particles as immunogens. Trends Microbiol. 2003;11:438-44.
5. Nitcheu Tefit J, Serra V. Outlining novel cellular adjuvant products for therapeutic vaccines against cancer. Expert Rev Vaccines. 2011;10:1207-20.
6. Pattenden LK, Middelberg APJ, Niebert M, Lipin DI. Towards the preparative and large-scale precision manufacture of virus-like particles. Trends Biotechnol. 2005;23:523-9.
7. Brennan F, Jones T, Hamilton W. Cowpea mosaic virus as a vaccine carrier of heterologous antigens. Mol Biotechnol. 2001;17:15-26.
8. Roth J-F. The yeast Ty virus-like particles. Yeast. 2000;16:785-95.
9. Kushnir N, Steatfield SJ, Yousibov V. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine. 2012;31(1):58-83.
10. Stahl SJ, Murray K. Immunogenicity of peptide fusions to hepatitis B virus core antigen. Proc Natl Acad Sci. 1989;86:6283-7.
11. Murata Y, Lightfoote P, Rose R, Walsh E. Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres. Virol J. 2009;6:81.
12. Cornuz J, Zwahlen S, Jungi WF, Osterwalder J, Klingler K, van Melle G, et al. A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial. PLoS One. 2008;3:e2547.
13. Denis J, Acosta-Ramirez E, Zhao Y, Hamelin M-E, Koukavica I, Baz M, et al. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine. 2008;26:3395-403.
14. Lacasse P, Denis J, Lapointe R, Leclerc D, Lamarre A. Novel Plant Virus-Based Vaccine Induces Protective Cytotoxic T-Lymphocyte-Mediated Antiviral Immunity through Dendritic Cell Maturation. J Virol. 2008;82:785-94.
15. Caldeira J, Peabody D. Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides. J Nanobiotechnology. 2011;9:22.
16. Koo M, Bendahmane M, Lettieri GA, Paoletti AD, Lane TE, Fitchen JH, et al. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc Natl Acad Sci. 1999;96:7774-9.
17. Sainsbury F, Cañizares MC, Lomonossoff GP. Cowpea mosaic Virus: The Plant Virus-Based Biotechnology Workhorse. Annu Rev Phytopathol. 2010;48:437-55.
18. Ahlquist P. Bromovirus RNA replication and transcription. Curr Opin Gen Develop. 1992;2:71-6.
19. Zhao X, Fox JM, Olson NH, Baker TS, Young MJ. In vitro assembly of cowpea chlorotic mottle virus from coat protein expressed in Escherichia coli and in vitro-transcribed viral cDNA. Virology. 1995;207:486-94.
20. Speir JA, Bothner B, Qu C, Willits DA, Young MJ, Johnson JE. Enhanced Local Symmetry Interactions Globally Stabilize a Mutant Virus Capsid That Maintains Infectivity and Capsid Dynamics. J Virol. 2006;80:3582-91.
21. Vriend G, Verduin BJ, Hemminga MA. Role of the N-terminal part of the coat protein in the assembly of cowpea chlorotic mottle virus. A 500 MHz proton nuclear magnetic resonance study and structural calculations. J Mol Biol. 1986;191:453-60.
22. Comellas-Aragonès M, Engelkamp H, Claessen VI, Sommerdijk NAJM, Rowan AE, Christianen PCM, et al. A virus-based single-enzyme nanoreactor. Nat Nanotechnol. 2007;2:635-9.
23. Minten IJ, Hendriks LJA, Nolte, RJM, Cornelissen JJLM. Controlled encapsulation of multiple proteins in virus capsids. J Am Chem Soc. 2009;131:17771-3.
24. Kaiser CR, Flenniken ML, Gillitzer E, Harmsen AL, Harmsen AG, Jutila MA, et al. Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int J Nanomedicine. 2007;2(4):715-33.
25. Brumfield S, Willits D, Tang L, Johnson JE, Douglas T, Young M. Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. J Gen Virol. 2004;85:1049-53.
26. Phelps JP, Dao P, Jin H, Rasochova L. Expression and self-assembly of cowpea chlorotic mottle virus-like particles in Pseudomonas fluorescens. J Biotechnol. 2007;128:290-6.
27. Cantin G, Resnick S, Jin H, O'Hanlon R, Espinosa O, Stevens A, et al. Comparison of Methods for Chemical Conjugation of an Influenza Peptide to Wild-Type and Cysteine-Mutant Virus-Like Particles Expressed in Pseudomonas fluorescens. Int J Peptide Res Ther. 2011;17:217-24.
28. Porta C, Spall VE, Findlay KC, Gergerich RC, Farrance CE, Lomonossoff GP. Cowpea mosaic virus-based chimeras. Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses. Virology. 2003;310:50-63.
29. Brown SD, Fiedler JD, Finn MG. Assembly of hybrid bacteriophage Qbeta virus-like particles. Biochemistry. 2009;48:11155-7.
30. Bancroft JB, McDonald JG, Rees MW. A mutant of Cowpea chlorotic mottle virus with a perturbed assembly mechanism. Virology. 1976;75:293-305.
31. Douglas T, Young M. Host-guest encapsulation of materials by assembled virus protein cages. Nature. 1998;152-158.
32. Mikkilä J, Eskelinen A-P, Niemelä EH, Linko V, Frilander MJ, Törmä P, et al. Virus-encapsulated DNA origami nanostructures for cellular delivery. Nano Lett. 2014;14(4):2196-200.
33. Kusters R, Lin H-K, Zandi R, Tsvetkova I, Dragnea B, van der Schoot P. Role of charge regulation and size polydispersity in nanoparticle encapsulation by viral coat proteins. J Phys Chem. 2015;119(5):1869-80.
34. Schuller VJ, Heidegger S, Sandholzer N, Nickels PC, Suhartha NA, Endres S, et al. Cellular immunostimulation by CpG-sequence-coated DNA origami structures. ACS Nano. 2011;5(12):9696-702.
35. Malik Peiris JS, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev. 2007;20(2):243-67.
36. Keeling MJ, Woolhouse MEJ, May RM, Davis G, Grenfell BT. Modelling vaccination strategies against foot and mouth disease. Nature. 2003;421:136-42.
37. Liu W, Zou P, Ding J, Lu Y, Chen Y-H. Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design. Microbes Infect. 2005;7:171-7.
38. Haghighi HR, Read LR, Haeryfar SMM, Behboudi S, Sharif S. Identification of a Dual-Specific T Cell Epitope of the Hemagglutinin Antigen of an H5 Avian Influenza Virus in Chickens. PLoS One. 2009;4(11):e7772.
39. Beard CW, Mason PW. Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol. 2000;74:987-91.
40. Yang D, Zhang C, Zhao L, Zhou G, Wang H, Yu L. Identification of a conserved linear epitope on the VP1 protein of serotype O foot-and-mouth disease virus by neutralizing monoclonal antibody 8E8. Virus Res. 2011;155:291-9.
41. Zamorano P, Wigdorovitz A, Chaher M, Fernandez F, Carrillo C, Arcovecchio FE, et al. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos. Virology. 1994;201:383-7.
42. Andrianova EP, Krementsugskaia SR, Lugovskaia NN, Mayorova TK, Borisov VV, Eldarov MA, et al. Foot and mouth disease virus polyepitope protein produced in bacteria and plants induces protective immunity in guinea pigs. Biochemistry. 2011;76:339-46.
43. van Lent JWM, Verduin BJM. Specific gold-labeling of antibodies bound to plant viruses in mixed suspensions. Netherlands J Plant Pathol. 1985;91:205-13.
44. Lamb JW, Duncan GH, Reavy B, Gildow FE, Mayo MA, Hay RT. Assembly of virus-like particles in insect cells infected with a baculovirus containing a modified coat protein gene of potato leafroll luteovirus. J Gen Virol. 1996;77:1349-58.
45. Joelson T, Åkerblom L, Oxelfelt P, Strandberg B, Tomenius, Morris TJ. Presentation of a foreign peptide on the surface of tomato bushy stunt virus. J Gen Virol. 1997;78:1213-7.
46. Kumar S, Ochoa W, Singh P, Hsu C, Schneemann A, Manchester M, et al. Tomato bushy stunt virus (TBSV), a versatile platform for polyvalent antigenic epitopes and vaccine design. Virology. 2009;388(1):185-90.
47. Nemchinov LG, Liang TJ, Rifaat MM, Mazyad HM, Hadidi A, Keith JM. Development of a plant-derived subunit vaccine candidate against hepatitis C virus. Arch Virol. 2000;145(12):2557-73.
48. Taylor KM, Lin T, Porta C, Mosser AG, Giesing HA, Lomonossoff GP, et al. Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus. J Mol Recognit. 2000;13(2):71-82.
49. Saini M, Vrati S. A Japanese Encephalitis Virus Peptide Present on Johnson Grass Mosaic Virus-Like Particles Induces Virus-Neutralizing Antibodies and Protects Mice against Lethal Challenge. J Virol. 2003;77:3487-94.
50. Brodzik R, Bandurska K, Deka D, Golovkin M, Koprowski H. Advances in alfalfa mosaic virus-mediated expression of anthrax antigen in planta. Biochem Biophys Res Commun. 2005;338(2):717-22.
51. Hema M, Nagendrakumar SB, Yamini R, Chandran D, Rajendra L, Thiagarjan D, et al. Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies. Vaccine. 2007;25(25):4784-94.
52. Natilla A, Nemchinov LG. Improvement of PVX/CMV CP expression tool for display of short foreign antigens. Protein Expr Purif. 2008;59(1):117-21.
53. Rioux G, Babin C, Majeau N, Leclerc D. Engineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sites. PLoS One. 2012;7(2):e31925.
54. Rubino L, De Stradis A, Russo M, Martelli GP. Generation of virus-like particles in plants expressing the capsid protein of Cymbidium ringspot virus. J Plant Pathol. 2011;93(3):751-6.
55. Kalnciema I, Skrastina D, Ose V, Pumpens P, Zeltins A. Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches. Mol Biotechnol. 2012;52(2):129-39.
56. Chen TH, Chen TH, Hu CC, Liao JT, Lee JW, Lin MY, et al. Induction of protective immunity in chickens immunized with plant-made chimeric Bamboo mosaic virus particles expressing very virulent infectious bursal disease virus antigen. Virus Res. 2012;166(1-2):109-15.
57. Sánchez F, Sáez M, Lunello P, Ponz F. Plant viral elongated nanoparticles modified for log-increases of foreign peptide immunogenecity and specific antibody detection. J Biotechnol. 2013;168(4):409-15.
58. Damodharan S, Gujar R, Pattabiraman S, Nesakumar M, Hanna LE, Vadakkuppattu RD, et al. Expression and immunological characterization of caradamom mosaic virus coat protein displaying HIV gp41 epitopes. Microbiol Immunol. 2013;57(5):374-85.
59. Arcangeli C, Circelli P, Donini M, Aljabali AA, Benvenuto E, Lomonossoff GP, et al. Structure-based design and experimental engineering of a plant virus nanoparticle for the presentation of immunogenic epitopes and as a drug carrier. J Biomol Struct Dyn. 2014;32(4):630-47.
60. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera- a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605-12.